Medicine Ban: There is a major news for common people. The national government has implemented a significant measure to enhance the safety and scientific validity of medication use in the country. The Union Health Ministry has immediately prohibited the production, sale, and distribution of 16 fixed-dose combination (FDC) drugs. These medications were deemed to lack sufficient clinical justification, with potential risks outweighing their benefits.
What are fixed-dose combinations?
Fixed-dose combination (FDC) drugs are formulations that blend multiple active pharmaceutical ingredients in specified proportions. While these combinations offer convenience, they can pose health risks if not scientifically supported. This decision by the Health Ministry followed a thorough evaluation prompted by directives from the Supreme Court. An expert committee established by the Drugs Technical Advisory Board (DTAB) conducted the review, identifying unnecessary, unscientific, or potentially harmful drug combinations.
What did the investigation reveal?
The investigation found that 16 drug combinations lacked clear medical rationale, leading to their removal from the market. The ministry emphasized that these medications were not proving beneficial and could pose health hazards.
Drugs that have been banned
The banned drugs include specific pain relievers, muscle relaxants, antibiotic combinations, and skincare products. Examples include mixtures of amoxicillin and serratiopeptidase, certain amoxicillin and cloxacillin-based drugs, cefadroxil and probenecid combinations, as well as medications containing cefuroxime and serratiopeptidase.
Skincare and beauty products
Additionally, certain skincare and beauty products containing blends of ingredients like Vitamin E, Jojoba oil, Orange oil, Wheat germ oil, Tea tree oil, Allantoin, and D-Panthenol with Aloe Vera have been prohibited. This ban has been enforced under Section 26A of the Drugs and Cosmetics Act, 1940, with the aim of safeguarding patients and promoting the appropriate use of medicines.
State drug controllers, regulatory bodies, and enforcement authorities have been instructed to strictly adhere to this directive. Manufacturers, importers, and distributors of drugs have been urged to take immediate action. Experts believe that this measure will ensure that only medications with scientifically proven efficacy and safety remain available, thereby enhancing patient care and safety.